Today's forecast for the adjuvant treatment of pancreatic cancer: Clear or cloudy?

ONCOLOGY

Volumn 21, Issue 6, 2007, Pages 720-725

  Picozzi, Vincent J ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; TUMOR MARKER;

ANOREXIA; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE FREE SURVIVAL; GASTROINTESTINAL TOXICITY; HUMAN; MUCOSA INFLAMMATION; NAUSEA; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATIENT SELECTION; POSTOPERATIVE PERIOD; REVIEW; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; ULTRASOUND; VOMITING;

EID: 34249883907     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56:106-130, 2006.
2. Sener S, Fremgen A, Menck H, et al: Pancreatic cancer: A report of treatment and survival trends for 100,313 patients using the National Cancer Database. J Am Coll Surg 189:1-7, 1999.
3. Pisters P, Picozzi V, Abrams R: Therapy for localized pancreatic adenocarcinoma: One, Two or Three Modalities? ASCO Educational Book, pp 397-418. Alexandria, Va; American Society of Clinical Oncology, 2003.
4. Birkmeyer J, Siewers A, Findlayson E, et al: Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128-1137, 2002.
5. Heinemann V, Hinke A, Boeck S, et al: Benefit from gemcitabine-based combination treatment in advanced pancreatic cancer: A meta-analysis of randomized trials (abstract 129). Proceedings of the 2007 Gastrointestinal Cancers Symposium; Orlando, Fla; January 19-21, 2007.
6. Laheru D, Yeo C, Bierdrzycki B, et al: A safety and efficacy trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene in combination with adjuvant chemoradiotherapy for the treatment of adenocarcinoma of the pancreas (abstract 106). Proceedings of the 2007 Gastrointestinal Cancers Symposium; Orlando, Fla; January 19-21, 2007.
7. Abrams R, Winter K, Regine W, et al: RTOG 9704 - radiotherapy quality assurance and review (abstract 39). Int J Radiat Oncol Biol Phys 66(3 suppl):S22, 2006.
8. Moutardier V, Turini O, Huiart L, et al: A reappraisal of postoperative chemoradiation for localized pancreatic head ductal adenocarcinoma in a 5-year single institution experience. J Gastrointest Surg 8:502-510, 2004.
9. Picozzi V, Kozarek R, Traverso L: Interferon-based adjuvant chemoradiation after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 285:476-480, 2003.